CAPILLARY
Capillary Technologies India Limited (capillary) Announces Hero Cycles Selects Capillary to Power Loyalty Across its 3,000+ Dealer Network
Capillary Technologies CAPILLARY partners with Hero Cycles to launch a loyalty program across its 3,000+ dealer network, aiming to strengthen relationships a.
Capillary Technologies India Limited (CAPILLARY) has announced that Hero Cycles, India’s largest bicycle manufacturer, has selected CAPILLARY to power a new dealer loyalty program across its network of more than 3,000 dealers nationwide. The program has already been launched with 50 dealers, marking the first phase of a broader rollout across Hero Cycles’ dealer ecosystem.
Strengthening Dealer Relationships
The initiative will help Hero Cycles strengthen dealer relationships through a more unified, data-driven approach to rewards, engagement, and performance. With one of the largest dealer networks in the Indian bicycle industry, Hero Cycles is looking to build on its existing incentive initiatives with deeper channel insights, more personalized rewards, and sustained engagement mechanisms.
Seamless Integration and Rewards
Capillary’s platform will be integrated with Hero Cycles’ existing BIZOM app, creating a seamless experience for dealers. The program will recognize and reward a range of activities, including sell-out performance, training participation, store branding, and cross-category selling. Through personalized rewards, gamified experiences, and greater visibility into dealer engagement, Hero Cycles aims to build a more structured and continuous relationship with its dealer network.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Application sector. Here’s a quick read on where the business and the stock stand today.
Capillary trades in the lower quarter of its 52-week range. Thin margins at 7.1% leave limited room for error — any demand softness or cost spike hits the bottom line hard. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. The stock sits at 21% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. The stock rises -4.2% in three months on 42.2% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited Q2 Fy2027: Operating Revenue Up 51% Yoy
Capillary Technologies India Limited (CAPILLARY) reports 51% YoY growth in operating revenue for Q2 FY2027, with 103% growth in Adjusted EBITDA.
Capillary Technologies India Limited (CAPILLARY) announced its financial results for the second quarter and half year ended September 30, 2026. The company reported strong revenue growth of 51% year-on-year (43% in constant currency) and 103% growth in Adjusted EBITDA for the quarter ended September 30, 2026. This growth reflects strong expansion across existing customers, rising contributions from new annual contract value, and the inclusion of revenues from SessionM, Capillary’s most recent acquisition completed in May 2026.
Quarterly Performance
For Q2 FY2027, compared to the same quarter last year, the company reported:
- Operating Revenue of ₹ 2,713.5 Mn. vs. ₹ 1,793.3 Mn. (+51% YoY; +43% YoY CC)
- Adjusted EBITDA of ₹ 448.6 Mn. vs. ₹ 220.8 Mn. (+103% YoY)
- PAT of ₹ 219.2 Mn. vs. ₹ 2.9 Mn. (+7,505% YoY)
Half-Year Performance
For H1 FY2027, compared to the same period last year, the company reported:
- Operating Revenue of ₹ 5,280.0 Mn. vs. ₹ 3,592.2 Mn. (+47% YoY; +38% YoY CC)
- Adjusted EBITDA of ₹ 888.8 Mn. vs. ₹ 410.6 Mn. (+116% YoY)
- PAT of ₹ 123.7 Mn. vs. ₹ 10.3 Mn. (+1,097% YoY)
Commenting on Q2 FY2027 results, Aneesh Reddy Boddu, Founder, MD & CEO, said, “We delivered another strong quarter, driven by continued Net Revenue Retention (NRR) expansion and new enterprise wins across global markets. SessionM, which we acquired from Mastercard last quarter, is performing as planned and has achieved breakeven; our integration plans are on track. Artificial Intelligence has become a major tailwind for our business with aiRA and our broader AI capabilities underpinning key new ACV wins this quarter which are up 79% YoY on a TTM basis (excluding an exceptional new contract value from our first entry into the healthcare vertical). We also completed our first customer migration using our AI-powered migration technology, which positions us to move acquired customers onto the Capillary platform faster and more efficiently. We are seeing strong momentum in our Order book across Geographies. Looking ahead, we remain focused on sustainable organic growth and profitability, while scaling AI across our platform, our customer migrations and our own operations.”
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Application sector. Here’s a quick read on where the business and the stock stand today.
Capillary rises 11.0% over three months, with buying pressure holding steady. Thin margins at 5.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. The stock holds at 30% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at 42.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited (capillary) Appoints Bill Swift as President, Americas
Capillary Technologies India Limited (CAPILLARY) appoints Bill Swift as President, Americas, strengthening its US leadership and growth strategy.
Capillary Technologies India Limited (CAPILLARY) announced the appointment of Bill Swift as President, Americas, on October 29, 2026. This strategic move underscores Capillary’s commitment to deepening its presence across the Americas. Swift brings nearly 30 years of experience in helping leading brands build lasting customer relationships and drive measurable business results.
Leadership Expertise
Swift previously served as CEO of Brierley, a company that pioneered in loyalty solutions. His role at Brierley+Partners, where he helped create a successful loyalty platform, has equipped him with deep insights into loyalty strategies. Since joining Capillary in 2023, Swift has been instrumental in integrating acquisitions and shaping Capillary’s growth trajectory.
Strategic Vision for Americas
In his new role, Swift will lead Capillary’s business operations across the Americas, focusing on sales, client success, and delivery. He aims to drive growth with enterprise brands in retail, hospitality, travel, airlines, and other major sectors. Swift emphasizes that loyalty should be viewed as a catalyst for growth, facilitated by technology that delivers powerful customer experiences and business results.
“Loyalty has always been about earning the right to a lasting relationship with the customer,” said Bill Swift. “The most successful brands now see loyalty as a catalyst for growth, driven by technology that delivers real business results.”
Anant Choubey, co-founder & COO of Capillary, highlighted Swift’s strategic depth and understanding of customer relationships, stating, “His leadership was essential to Brierley+Partners’ success, and he is the right leader to accelerate our growth across the Americas.”
Founded in 2012, Capillary Technologies helps brands leverage lasting customer relationships to achieve measurable growth. Its AI-powered platform integrates loyalty, data, and engagement to deliver personalized experiences, strengthening retention and growing customer lifetime value.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Application sector. Here’s a quick read on where the business and the stock stand today.
Capillary rises 11.0% over three months, with buying pressure holding steady. Thin margins at 5.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. The stock holds at 30% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at 42.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) eases after clearing resistance, down 5% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) shows pressure after breakout, moving down 5% intraday.
Capillary Technologies India Limited (CAPILLARY) pulls back from breakout highs, falling 5% to ₹530.4 on the NSE today. This retracement comes after the stock cleared a crucial 6-month resistance level at ₹512, marking a structural breakout. The pullback today is likely due to profit-taking following this breakout. Capillary Technologies operates in the technology sector, specifically in software infrastructure. Today’s move appears to be company-specific rather than a sector-wide trend, as it follows the breakout and subsequent profit-taking.
Technical setup — trendlines & DMA
The current 6-month trendline structure shows a breakout above the resistance level at ₹512, with the stock now trading 3.5% above this resistance. The 6-month support trendline is at ₹464.21, which is 12.48% below today’s price. The stock is currently trading 11% above the 50-day moving average (DMA) at ₹505.2, indicating an extended move. However, it is slightly below the 200-DMA at ₹560.7. The stock is in the lower third of its 52-week range, trading 20% above the 52-week low and 33.6% below the 52-week high, suggesting there is still room for further upside within the year.
Snapshot: ₹530.40 on 2026-08-10 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 81.7 and profit margins at 5.2%, Capillary Technologies is trading at a high valuation relative to its current earnings. The revenue CAGR of 34.0% indicates strong growth, but the thin profit margins suggest that the market may be pricing in future improvements or a potential turnaround. The 20.6% institutional ownership suggests that smart money has a moderate level of confidence in the company, though it is not overwhelmingly bullish. There is no NSE catalyst today, so the move is primarily technical.
Algorithmic scorecard
The overall algorithmic scorecard reflects a technically strong but fundamentally weak position for Capillary Technologies. The strongest signals include the revenue and profit CAGRs, which are excellent at 34.0% and 27.0%, respectively, indicating robust growth. Additionally, the very low debt level with a D/E ratio of 0.00 points to excellent financial health. On the weaker side, the low profit margin of 5.2% leaves little room for error, and the PEG ratio of 3.03 suggests the stock is overvalued relative to its growth rate. The negligible dividend yield also means there is little to no income generation from this investment.
Company outlook
Management expects EBITDA margins to remain sustainable, with a potential dip due to the SessionM acquisition. The core organic business is projected to reach a steady-state EBITDA margin of 25-30%. Revenues are anticipated to exceed INR 1,000-1,050 crores in FY27, driven by both the SessionM acquisition and organic growth. SessionM is expected to significantly contribute to revenue growth and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
-
Financial Services2 days agoSammaan Capital Limited (sammaancap) Q2 FY27: Disbursements Rise 62% Qoq and PAT Grows 28%
-
BIL3 days agoBhartiya International Limited (BIL) Q2 FY27: Robust Revenue Growth Accompanied by Strong PAT Expansion
-
Consumer Cyclical2 days agoSenco Gold Limited (senco) Investor Presentation Q2 & H1 FY27 Highlights
-
Communication Equipment2 days agoTamilnadu Telecommunication Limited (tntele) Reports Q2 FY27: Net Loss Deepens
-
Financial Services2 days agoSammaan Capital Limited (sammaancap) Q2fy27 Investor Presentation: Strong Growth and Expansion
-
Healthcare2 days agoZydus Lifesciences Limited (zyduslife) Inspection by USFDA Concludes at Liqmeds, UK
-
Capital Markets2 days agoMaster Trust Limited (mastertr): Mastercapitalservices Raises ₹75 Cr Through Ncds
-
MAXESTATES1 day agoMax Estates Limited (maxestates) Reimagines Luxury Living Through ‘the Bungalows’
